Interpretation of

doi:10.12280/gjszjk.20220031

Abstract

Abstract:

Postpartum pain is a common problem for pregnant women. Improper treatment may lead to adverse consequences such as greater opioid use, postpartum depression, and development of persistent pain. Therefore, ACOG put forward clinical consensus about the recommendations on pharmacologic stepwise multimodal approach for postpartum pain management in 2021, especially for acute perineal, uterine and incisional pain. In addition, it also provides advices for the treatment of postpartum pain when breastfeeding or discharge, and emphasizes the principle of individualized medication. The recommended clinical medication can follow the step-by-step administration of "non-opioid analgesics (such as acetaminophen and non-steroidal anti-inflammatory drugs) - weak opioids - strong opioids (if necessary)". Those can be combined reasonably. We tried to interpreted the main viewpoints of this clinical consensus in this review.

Key words: Pain, Analgesia, Disease management, Postpartum pain, Stepwise, Multimodal approach

WANG Bin, GUAN Bo-yang, TIAN Yun, SUN Ying, ZHUANG Guo-li. Interpretation of "2021 ACOG Clinical Consensus: Pharmacologic Stepwise Multimodal Approach for Postpartum Pain Management"[J]. Journal of International Reproductive Health/Family Planning, 2022, 41(4): 347-352.

Figures/Tables 1

References 32

[1]	American College of Obstetricians and Gynecologists′ Committee on Clinical Consensus-Obstetrics. Pharmacologic Stepwise Multimodal Approach for Postpartum Pain Management: ACOG Clinical Consensus No. 1[J]. Obstet Gynecol, 2021, 138(3):507-517. doi: 10.1097/AOG.0000000000004517. doi: 10.1097/AOG.0000000000004517 URL
[2]	Declercq E, Cunningham DK, Johnson C, et al. Mothers′ reports of postpartum pain associated with vaginal and cesarean deliveries: results of a national survey[J]. Birth, 2008, 35(1):16-24. doi: 10.1111/j.1523-536X.2007.00207.x. doi: 10.1111/j.1523-536X.2007.00207.x pmid: 18307483
[3]	Prabhu M, McQuaid-Hanson E, Hopp S, et al. A Shared Decision-Making Intervention to Guide Opioid Prescribing After Cesarean Delivery[J]. Obstet Gynecol, 2017, 130(1):42-46. doi: 10.1097/AOG.0000000000002094. doi: 10.1097/AOG.0000000000002094 URL
[4]	Lee P, Le Saux M, Siegel R, et al. Racial and ethnic disparities in the management of acute pain in US emergency departments: Meta-analysis and systematic review[J]. Am J Emerg Med, 2019, 37(9):1770-1777. doi: 10.1016/j.ajem.2019.06.014. doi: 10.1016/j.ajem.2019.06.014 URL
[5]	Leung L. From ladder to platform: a new concept for pain management[J]. J Prim Health Care, 2012, 4(3):254-258. doi: 10.1071/HC12258 URL
[6]	Mullman L, Hilden P, Goral J, et al. Improved Outcomes With an Enhanced Recovery Approach to Cesarean Delivery[J]. Obstet Gynecol, 2020, 136(4):685-691. doi: 10.1097/AOG.0000000000004023. doi: 10.1097/AOG.0000000000004023 URL
[7]	Carvalho B, Butwick AJ. Postcesarean delivery analgesia[J]. Best Pract Res Clin Anaesthesiol, 2017, 31(1):69-79. doi: 10.1016/j.bpa.2017.01.003. doi: S1521-6896(17)30003-4 pmid: 28625307
[8]	Anastasio HB, Campbell LE, Buermeyer A, et al. Nonsteroidal Antiinflammatory Drug Administration and Postpartum Blood Pressure in Women With Hypertensive Disorders of Pregnancy[J]. Obstet Gynecol, 2018, 132(6):1471-1476. doi: 10.1097/AOG.0000000000002979. doi: 10.1097/AOG.0000000000002979 pmid: 30399109
[9]	Hirshberg JS, Cahill AG. Pain relief: determining the safety of ibuprofen with postpartum preeclampsia[J]. Am J Obstet Gynecol, 2018, 218(6):547-548. doi: 10.1016/j.ajog.2018.04.026. doi: S0002-9378(18)30323-5 pmid: 29793573
[10]	American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy[J]. Obstet Gynecol, 2019, 133(1):e26-e50. doi: 10.1097/AOG.0000000000003020. doi: 10.1097/AOG.0000000000003020 URL
[11]	Viteri OA, England JA, Alrais MA, et al. Association of Nonsteroidal Antiinflammatory Drugs and Postpartum Hypertension in Women With Preeclampsia With Severe Features[J]. Obstet Gynecol, 2017, 130(4):830-835. doi: 10.1097/AOG.0000000000002247. doi: 10.1097/AOG.0000000000002247 pmid: 28885417
[12]	Wasden SW, Ragsdale ES, Chasen ST, et al. Impact of non-steroidal anti-inflammatory drugs on hypertensive disorders of pregnancy[J]. Pregnancy Hypertens, 2014, 4(4):259-263. doi: 10.1016/j.preghy.2014.06.001. doi: 10.1016/j.preghy.2014.06.001 pmid: 26104814
[13]	Vigil-De Gracia P, Solis V, Ortega N. Ibuprofen versus acetaminophen as a post-partum analgesic for women with severe pre-eclampsia: randomized clinical study[J]. J Matern Fetal Neonatal Med, 2017, 30(11):1279-1282. doi: 10.1080/14767058.2016.1210599. doi: 10.1080/14767058.2016.1210599 pmid: 27384376
[14]	Blue NR, Murray-Krezan C, Drake-Lavelle S, et al. Effect of ibuprofen vs acetaminophen on postpartum hypertension in preeclampsia with severe features: a double-masked, randomized controlled trial[J]. Am J Obstet Gynecol, 2018, 218(6):616.e1-e8. doi: 10.1016/j.ajog.2018.02.016. doi: 10.1016/j.ajog.2018.02.016
[15]	Yoon E, Babar A, Choudhary M, et al. Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update[J]. J Clin Transl Hepatol, 2016, 4(2):131-142. doi: 10.14218/JCTH.2015.00052. doi: 10.14218/JCTH.2015.00052
[16]	Fahey JO. Best Practices in Management of Postpartum Pain[J]. J Perinat Neonatal Nurs, 2017, 31(2):126-136. doi: 10.1097/JPN.0000000000000241. doi: 10.1097/JPN.0000000000000241
[17]	McNicol ED, Ferguson MC, Hudcova J. Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain[J]. Cochrane Database Syst Rev, 2015, 2015(6): CD003348. doi: 10.1002/14651858.CD003348.pub3. doi: 10.1002/14651858.CD003348.pub3
[18]	Ng QX, Loke W, Yeo WS, et al. A Meta-Analysis of the Utility of Preoperative Intravenous Paracetamol for Post-Caesarean Analgesia[J]. Medicina(Kaunas), 2019, 55(8):424. doi: 10.3390/medicina55080424. doi: 10.3390/medicina55080424
[19]	Ituk U, Thenuwara K. The effect of a single intraoperative dose of intravenous dexamethasone 8 mg on post-cesarean delivery analgesia: a randomized controlled trial[J]. Int J Obstet Anesth, 2018, 35:57-63. doi: 10.1016/j.ijoa.2018.03.008. doi: S0959-289X(17)30431-4 pmid: 29773484
[20]	Eslamian L, Jalili Z, Jamal A, et al. Transversus abdominis plane block reduces postoperative pain intensity and analgesic consumption in elective cesarean delivery under general anesthesia[J]. J Anesth, 2012, 26(3):334-338. doi: 10.1007/s00540-012-1336-3. doi: 10.1007/s00540-012-1336-3 pmid: 22354671
[21]	Mukhtar K. Transversus abdominis plane (TAP) block[EB/OL]. [2021-06-21]. http://www.nysora.com/files/2013/pdf/TRANSVER-SUS-ABDOMINIS-PLANE(TAP).pdf.
[22]	Mitchell KD, Smith CT, Mechling C, et al. A review of peripheral nerve blocks for cesarean delivery analgesia[J]. Reg Anesth Pain Med, 2020, 45:52-62. doi: 10.1136/rapm-2019-100752. doi: 10.1136/rapm-2019-100752 URL
[23]	Ilett KF, Kristensen JH. Drug use and breastfeeding[J]. Expert Opin Drug Saf, 2005, 4(4):745-768. doi: 10.1517/14740338.4.4.745. doi: 10.1517/14740338.4.4.745 URL
[24]	National Library of Medicine. Drugs and lactation database (LactMed)[M/OL]. [2021-06-16]. https://www.ncbi.nlm.nih.gov/books/NBK500998/.
[25]	Yurashevich M, Pedro C, Fuller M, et al. Intra-operative ketorolac 15 mg versus 30 mg for analgesia following cesarean delivery: A retrospective study[J]. Int J Obstet Anesth, 2020, 44:116-121. doi: 10.1016/j.ijoa.2020.08.009. doi: S0959-289X(20)30114-X pmid: 32947103
[26]	Kirchheiner J, Schmidt H, Tzvetkov M, et al. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication[J]. Pharmacogenomics J, 2007, 7(4):257-265. doi: 10.1038/sj.tpj.6500406. doi: 10.1038/sj.tpj.6500406 pmid: 16819548
[27]	Koren G, Cairns J, Chitayat D, et al. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother[J]. Lancet, 2006, 368(9536):704. doi: 10.1016/S0140-6736(06)69255-6. doi: 10.1016/S0140-6736(06)69255-6
[28]	U.S. Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women[EB/OL]. (2018-03-08)[2021-06-16]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-restricts-use-prescription-codeine-pain-and-cough-medicines-and.
[29]	Lam J, Kelly L, Ciszkowski C, et al. Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia[J]. J Pediatr, 2012, 160(1):33-37.e2. doi: 10.1016/j.jpeds.2011.06.050. doi: 10.1016/j.jpeds.2011.06.050 URL
[30]	Madadi P, Moretti M, Djokanovic N, et al. Guidelines for maternal codeine use during breastfeeding[J]. Can Fam Physician, 2009, 55(11):1077-1078.
[31]	Kelly LE, Chaudhry SA, Rieder MJ, et al. A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk[J]. PLoS One, 2013, 8(7):e70073. doi: 10.1371/journal.pone.0070073. doi: 10.1371/journal.pone.0070073 URL
[32]	Bateman BT, Cole NM, Maeda A, et al. Patterns of Opioid Prescription and Use After Cesarean Delivery[J]. Obstet Gynecol, 2017, 130(1):29-35. doi: 10.1097/AOG.0000000000002093. doi: 10.1097/AOG.0000000000002093 pmid: 28594763